Lv1
70 积分 2024-04-22 加入
Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study A Randomized Controlled Study of Benazepril and Losartan in Chronic Renal Insufficiency
16小时前
待确认
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension The KARDIA-2 Randomized Clinical Trial
12天前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial
12天前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
13天前
已完结
Aliskiren in Type 2 Diabetes and Cardiorenal End Points
14天前
已完结
Angiotensin-Converting Enzyme Inhibitors and Kidney Protection: The AIPRI Trial
14天前
已关闭
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
19天前
已完结
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
21天前
已完结
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
21天前
已完结
Integrated Single‐Cell Transcriptome and eQTL Analyses Reveal the Role of PZP in Aging and Chronic Kidney Disease
1个月前
已完结
皖公网安备34019202002308
